pancreatic body and tail carcinomas
Conditions
Sponsors
Yokohama City University, Gastroenterology Division
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: the patients with pancreatic body and tail carcinomas and with indication of EUS-FNA
Exclusion criteria
Exclusion criteria: (1) Patients with bleeding tendency (2) Patients under anticoaglant therapy (3) Plt< 30000
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity, specificity, accuracy and incidence of complication | — |
Countries
Japan
Contacts
Public ContactWatanabe Seitaro
Yokohama City University Hospital Gastroenterology Division
Outcome results
None listed